Literature DB >> 18602917

Abrogation of G2/M arrest sensitizes curcumin-resistant hepatoma cells to apoptosis.

Wei-Zhang Wang1, Jiasen Cheng, Jing Luo, Shi-Mei Zhuang.   

Abstract

In this study, we showed that curcumin treatment resulted in activation of Chk1-mediated G2 checkpoint, which was associated with the induction of G2/M arrest and the resistance of cancer cells to curcumin-induced apoptosis. Further investigation revealed that inhibition of Chk1 significantly abrogated G2/M arrest and sensitized curcumin-resistant cells to apoptosis via upregulation of Bad and in turn the loss of mitochondrial membrane potential. These results indicate that Chk1-mediated G2/M arrest may serve as a mechanism for curcumin resistance and Chk1 represents a potential target for the reversal of this resistance. Our findings should be helpful for clinical application of curcumin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602917     DOI: 10.1016/j.febslet.2008.06.048

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Therapeutic potential of curcumin in gastrointestinal diseases.

Authors:  Sigrid A Rajasekaran
Journal:  World J Gastrointest Pathophysiol       Date:  2011-02-15

2.  Kinase gene expression and subcellular protein expression pattern of protein kinase C isoforms in curcumin-treated human hepatocellular carcinoma Hep 3B cells.

Authors:  Hsin-Hsin Kao; Chao-Jung Wu; Shen-Jeu Won; Jyh-Wei Shin; Hsiao-Sheng Liu; Chun-Li Su
Journal:  Plant Foods Hum Nutr       Date:  2011-06       Impact factor: 3.921

Review 3.  Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Authors:  Jayaraj Ravindran; Sahdeo Prasad; Bharat B Aggarwal
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

4.  Yellow and green pigments from Calophyllum inophyllum L. seed oil induce cell death in colon and lung cancer cells.

Authors:  Chiawen Hsieh; Yun-Wei Lin; Ching-Hsein Chen; Wenjun Ku; Fuching Ma; Hanming Yu; Chishih Chu
Journal:  Oncol Lett       Date:  2018-02-14       Impact factor: 2.967

5.  C0818, a novel curcumin derivative, induces ROS-dependent cytotoxicity in human hepatocellular carcinoma cells in vitro via disruption of Hsp90 function.

Authors:  Ahmed Attia Ahmed Abdelmoaty; Ping Zhang; Wen Lin; Ying-Juan Fan; Sheng-Nan Ye; Jian-Hua Xu
Journal:  Acta Pharmacol Sin       Date:  2021-04-06       Impact factor: 6.150

6.  MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein.

Authors:  Ying Zhu; Yang Lu; Qi Zhang; Jing-Jing Liu; Tuan-Jie Li; Jian-Rong Yang; Chunxian Zeng; Shi-Mei Zhuang
Journal:  Nucleic Acids Res       Date:  2011-12-30       Impact factor: 16.971

7.  Coralyne Radiosensitizes A549 Cells by Upregulation of CDKN1A Expression to Attenuate Radiation Induced G2/M Block of the Cell Cycle.

Authors:  Aneta Węgierek-Ciuk; Michał Arabski; Karol Ciepluch; Kamil Brzóska; Halina Lisowska; Malwina Czerwińska; Tomasz Stępkowski; Krzysztof Lis; Anna Lankoff
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

8.  Hepatitis C virus core protein down-regulates p21(Waf1/Cip1) and inhibits curcumin-induced apoptosis through microRNA-345 targeting in human hepatoma cells.

Authors:  Tzu-Yue Shiu; Shih-Ming Huang; Yu-Lueng Shih; Heng-Cheng Chu; Wei-Kuo Chang; Tsai-Yuan Hsieh
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

9.  Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells.

Authors:  R P Sahu; S Batra; S K Srivastava
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

10.  Zygotic G2/M cell cycle arrest induced by ATM/Chk1 activation and DNA repair in mouse embryos fertilized with hydrogen peroxide-treated epididymal mouse sperm.

Authors:  Bin Wang; Zhiling Li; Chao Wang; Man Chen; Jianfeng Xiao; Xiaoyan Wu; Wanfen Xiao; Yu Song; Xiaoyan Wang
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.